WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Niro Ramachandran net worth and biography

Niro Ramachandran Biography and Net Worth

Insider of Akoya Biosciences

Niro joined Akoya in August 2020 to serve as the Chief Business Officer responsible for developing a robust roadmap and commercialization strategy for Akoya’s platforms. Niro has nearly two decades of experience in developing and commercializing products in the life science market. He has commercialized over 30 products across genomics and proteomics research markets. More recently, he served as the vice president of the spatial biology business unit at Nanostring Technologies (2014 – 2020). Prior to this, Niro led product development for the protein business unit at Life Technologies (2008-2014; acquired by Thermo Fisher). Niro received his Hon. BSc in Biochemistry from University of Toronto, and PhD from University of Windsor. He completed his post doctorate work at the Harvard Institute of Proteomics, Harvard University.

How old is Niro Ramachandran?: Dr. Ramachandran is currently 49 years old. There are 4 older executives and no younger executives at Akoya Biosciences. The oldest executive at Akoya Biosciences is Dr. Frederic G. Pla Ph.D., Chief Operating Officer, who is 65 years old. Learn More on Niro Ramachandran's age.
How do I contact Niro Ramachandran?: The corporate mailing address for Dr. Ramachandran and other Akoya Biosciences executives is , , . Akoya Biosciences can also be reached via phone at 855-896-8401 and via email at [email protected]. Learn More on Niro Ramachandran's contact information.
Has Niro Ramachandran been buying or selling shares of Akoya Biosciences?: Niro Ramachandran has not been actively trading shares of Akoya Biosciences during the last ninety days. Learn More on Niro Ramachandran's trading history.
Who are Akoya Biosciences' active insiders?: Akoya Biosciences' insider roster includes Garry Nolan (Director), Niro Ramachandran (Insider), and Robert Shepler (Director). Learn More on Akoya Biosciences' active insiders.
Are insiders buying or selling shares of Akoya Biosciences?: In the last twelve months, insiders at the sold shares 4 times. They sold a total of 30,000 shares worth more than $105,000.00. The most recent insider tranaction occured on June, 11th when CEO Brian Mckelligon sold 7,500 shares worth more than $15,600.00. Insiders at Akoya Biosciences own 7.3% of the company. Learn More about insider trades at Akoya Biosciences.
Information on this page was last updated on 6/11/2024.

Niro Ramachandran Insider Trading History at Akoya Biosciences

Niro Ramachandran Buying and Selling Activity at Akoya Biosciences

Akoya Biosciences Company Overview

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Today's Range

Now: $2.49

$2.34

$2.60

50 Day Range

MA: $2.63

$2.07

$3.24

2 Week Range

Now: $2.49

$1.88

$6.31

Volume

365,649 shs

Average Volume

239,451 shs

Market Capitalization

$123.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22